M. V. Kiselevsky

520 total citations
43 papers, 386 citations indexed

About

M. V. Kiselevsky is a scholar working on Immunology, Oncology and Mechanical Engineering. According to data from OpenAlex, M. V. Kiselevsky has authored 43 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 8 papers in Mechanical Engineering. Recurrent topics in M. V. Kiselevsky's work include Immunotherapy and Immune Responses (9 papers), Orthopaedic implants and arthroplasty (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). M. V. Kiselevsky is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Orthopaedic implants and arthroplasty (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). M. V. Kiselevsky collaborates with scholars based in Russia, United States and Australia. M. V. Kiselevsky's co-authors include N. Yu. Anisimova, Fedor Senatov, Andrei A. Gakh, Aleksey V. Maksimkin, Gianfranco Baronzio, С. В. Добаткин, Natalia Martynenko, E. A. Luk’yanova, K.V. Niaza and Edward Sanders and has published in prestigious journals such as SHILAP Revista de lepidopterología, RSC Advances and Journal of Alloys and Compounds.

In The Last Decade

M. V. Kiselevsky

34 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. V. Kiselevsky Russia 11 102 91 90 85 60 43 386
Konstantinos Kapnisis Cyprus 11 61 0.6× 79 0.9× 54 0.6× 29 0.3× 77 1.3× 24 445
Yixian Wang China 12 144 1.4× 56 0.6× 58 0.6× 56 0.7× 16 0.3× 31 439
M.F. Harmand France 11 170 1.7× 56 0.6× 77 0.9× 14 0.2× 106 1.8× 25 640
Congying Wei China 10 135 1.3× 42 0.5× 165 1.8× 12 0.1× 70 1.2× 13 520
Peiyu Sun China 13 89 0.9× 63 0.7× 112 1.2× 18 0.2× 33 0.6× 25 466
Zhennan Deng China 14 246 2.4× 146 1.6× 118 1.3× 39 0.5× 100 1.7× 31 526
Qinghe Han China 11 188 1.8× 120 1.3× 111 1.2× 24 0.3× 23 0.4× 31 464
Bingchen Chen China 12 83 0.8× 119 1.3× 29 0.3× 57 0.7× 34 0.6× 34 421
Tudor Petreuş Romania 10 100 1.0× 55 0.6× 69 0.8× 23 0.3× 32 0.5× 21 361

Countries citing papers authored by M. V. Kiselevsky

Since Specialization
Citations

This map shows the geographic impact of M. V. Kiselevsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. V. Kiselevsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. V. Kiselevsky more than expected).

Fields of papers citing papers by M. V. Kiselevsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. V. Kiselevsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. V. Kiselevsky. The network helps show where M. V. Kiselevsky may publish in the future.

Co-authorship network of co-authors of M. V. Kiselevsky

This figure shows the co-authorship network connecting the top 25 collaborators of M. V. Kiselevsky. A scholar is included among the top collaborators of M. V. Kiselevsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. V. Kiselevsky. M. V. Kiselevsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiselevsky, M. V., et al.. (2021). Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis. SHILAP Revista de lepidopterología. 7(4). 20–28.
2.
Kiselevsky, M. V., et al.. (2021). Predictive biomarkers of inhibitors immune checkpoints therapy in malignant tumors. Russian Journal of Pediatric Hematology and Oncology. 8(2). 73–83. 2 indexed citations
3.
Валиев, Т. Т., et al.. (2021). The latest trends in improving CAR-T cell therapy: from leukemia to solid malignant tumors. Russian Journal of Pediatric Hematology and Oncology. 8(2). 84–95. 3 indexed citations
4.
Rybalchenko, O. V., N. Yu. Anisimova, M. V. Kiselevsky, et al.. (2021). Effect of equal-channel angular pressing on structure and properties of Fe-Mn-С alloys for biomedical applications. Materials Today Communications. 30. 103048–103048. 9 indexed citations
6.
Караулов, А. В., et al.. (2019). INFLUENCE OF ANTIBODIES AGAINST CTLA-4 AND PD-1 UPON QUANTITIES OF THEIR TARGET RECEPTORS. SHILAP Revista de lepidopterología. 21(1). 59–68. 1 indexed citations
7.
Kiselevsky, M. V., et al.. (2019). Influence of Flavonoids on the Cytotoxic Activity of Mononuclear Blood Cells in Model Tests. Open Access Macedonian Journal of Medical Sciences. 7(12). 1900–1904. 1 indexed citations
8.
Kiselevsky, M. V., et al.. (2018). MicroRNA expression in melanocytes and melanoma cells. Russian Journal of Biotherapy. 17(3). 6–11.
9.
Maksimkin, Aleksey V., et al.. (2017). Impregnation of Ultra-High-Density Polyethylene with Unsymmetrical Disulfides in Subcritical Freon Media. Russian Journal of Physical Chemistry B. 11(7). 1173–1179. 5 indexed citations
10.
Kiselevsky, M. V., et al.. (2017). MODELING OF ORTHOTOPICAL GROWTH OF HUMAN KIDNEY CANCER WITH SUBCUTANEOUS XENOGRAFTS RPOCH1 ON IMMUNODEFICIENT MICE. Russian Journal of Biotherapy. 16(1). 51–60. 1 indexed citations
11.
Maksimkin, Aleksey V., et al.. (2017). Impregnation of Ultrahigh-Molecular-Weight Polyethylene with Amoxicillin in Subcritical Freon R22 Media. Russian Journal of Physical Chemistry B. 11(8). 1215–1222. 7 indexed citations
12.
Luk’yanova, E. A., N. Yu. Anisimova, Natalia Martynenko, et al.. (2017). Features of in vitro and in vivo behaviour of magnesium alloy WE43. Materials Letters. 215. 308–311. 32 indexed citations
13.
Shender, Victoria О., et al.. (2015). The Study of Protective Extracellular Proteome Staphylococcus aureus № 6. SHILAP Revista de lepidopterología. 14(6). 87–94.
14.
Senatov, Fedor, et al.. (2014). UHMWPE-based nanocomposite as a material for damaged cartilage replacement. Materials Science and Engineering C. 48. 566–571. 40 indexed citations
15.
Ахматова, Н. К., et al.. (2014). EFFECT OF STIMFORTE UPON MURINE MONONUCLEAR LEUKOCYTES AND LYMPHOID ORGANS DURING CYCLOPHOSPHAN TREATMENT. Medical Immunology (Russia). 13(2-3). 133–133. 1 indexed citations
16.
Ахматова, Н. К., et al.. (2014). INFLUENCE OF IMMUNOMODULATING AGENTS IMMUNOVAK VP-4 AND PROFETAL ON FUNCTIONAL ACTIVITY OF MONONUCLEAR LEUKOCYTES. Medical Immunology (Russia). 11(1). 15–15.
17.
Kiselevsky, M. V., et al.. (2014). The “Cavitary” Type of Angiogenesis by Gastric Cancer. Morphological Characteristics and Prognostic Value. Journal of Cancer. 5(5). 311–319. 10 indexed citations
19.
Anisimova, N. Yu., et al.. (2011). Possibility of Microorganism Elimination from the Blood Using Modified Coal Hemosorbents. Bulletin of Experimental Biology and Medicine. 151(2). 273–274. 2 indexed citations
20.
Efferth, Thomas, et al.. (2008). Hemoglobin-associated proteins isolated from blood serum of Ehrlich carcinoma-bearing mice. International Journal of Oncology. 32(4). 885–93. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026